Vancomycin does not enhance hypotension under anesthesia
Related Experiment Video
Updated: Aug 15, 2026

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
W E von Kaenel1, E L Bloomfield, L Amaranath
1Department of General Anesthesiology, Cleveland Clinic Foundation, Ohio 44106.
Abstract:
The rapid administration of vancomycin is associated with flushing and hypotension, a consequence of histamine release. The manufacturer discourages administering vancomycin to anesthetized patients, stating that vancomycin aggravates the hypotensive effects of anesthetics. To test this, we randomly assigned 36 adults (ASA classes I through III) to one of two groups: preinduction (Preind, n = 19) and postinduction (Postind, n = 17). Both groups received two different infusions: vancomycin (1 g/250 mL normal saline) and saline (250 mL normal saline) over 30-60 min. The Preind group received vancomycin before anesthesia was induced and saline was administered immediately after anesthesia was induced; for the Postind group, this order was reversed. This was done in a double-blind fashion. The anesthetic induction was standardized by the intravenous administration of thiopental and vecuronium and anesthetic maintenance by inhalation of nitrous oxide and enflurane. End-tidal enflurane, heart rate (HR), and blood pressure (BP) were measured every 3 min. Independent (unpaired) t-test was used in data analysis. The groups did not differ significantly. We conclude that vancomycin infusion may be given under anesthesia without significant adverse hemodynamic consequences if administered over a 30-60 min period of time.
Insights
Rapid vancomycin infusion can cause hypotension. This study found that administering vancomycin over 30-60 minutes during anesthesia did not cause significant adverse hemodynamic effects in patients.
Area of Science:
- Anesthesiology
- Pharmacology
- Critical Care Medicine
Background:
- Rapid vancomycin administration is linked to flushing and hypotension due to histamine release.
- Manufacturers advise against vancomycin use in anesthetized patients due to potential exacerbation of anesthetic-induced hypotension.
Purpose of the Study:
- To investigate the hemodynamic effects of vancomycin administration during anesthesia.
- To determine if vancomycin exacerbates hypotension in anesthetized patients when infused over 30-60 minutes.
Main Methods:
- A double-blind, randomized study assigned 36 adults (ASA I-III) to preinduction or postinduction vancomycin infusion groups.
- Both groups received vancomycin (1g/250mL saline) and saline infusions over 30-60 minutes.
- Standardized anesthetic induction and maintenance protocols were used, with continuous monitoring of end-tidal enflurane, heart rate, and blood pressure.
Main Results:
- No significant differences in hemodynamic parameters were observed between the preinduction and postinduction vancomycin groups.
- Vancomycin infusion, when administered over 30-60 minutes, did not lead to significant adverse hemodynamic consequences during anesthesia.
Conclusions:
- Vancomycin can be safely administered during anesthesia if infused over a 30-60 minute period.
- The study challenges the manufacturer's caution regarding vancomycin use in anesthetized patients under specific infusion conditions.
Related Concept Videos
Local Anesthetics: Pharmacokinetics
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

